Patents by Inventor Sébastien Chabaud

Sébastien Chabaud has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220142993
    Abstract: The present invention provides Afabicin-containing solid pharmaceutical compostions exhibiting superior dissolution characteristics. This beneficial effect is accomplished by the presence of a histidine compound for manufacturing the compositions. The present invention further provides methods for making such compositions and uses thereof.
    Type: Application
    Filed: February 14, 2020
    Publication date: May 12, 2022
    Applicant: Debiopharm International S.A.
    Inventors: Marie Decrette, Aude Anne-Laure Colin, Sebastien Chabaud
  • Patent number: 9150571
    Abstract: This invention relates to the discovery of novel forms of Compound 1, including solvates, hydrates, and other crystalline forms. These novel forms of Compound 1 may impart advantages in pharmaceutical formulations incorporating them, including improved stability and bioavailability.
    Type: Grant
    Filed: September 23, 2013
    Date of Patent: October 6, 2015
    Assignee: Curis, Inc.
    Inventors: Noel Hamill, James Moody, Sébastien Chabaud, Arnaud Hamel
  • Publication number: 20140088138
    Abstract: This invention relates to the discovery of novel forms of Compound 1, including solvates, hydrates, and other crystalline forms. These novel forms of Compound 1 may impart advantages in pharmaceutical formulations incorporating them, including improved stability and bioavailability.
    Type: Application
    Filed: September 23, 2013
    Publication date: March 27, 2014
    Applicant: Debiopharm International SA
    Inventors: Noel Hamill, James Moody, Sébastien Chabaud, Arnaud Hamel